<DOC>
	<DOCNO>NCT02142114</DOCNO>
	<brief_summary>The purpose study determine small needle size reduces discomfort suffer patient follow intravitreal injection . It investigators belief use small size needle help patient less fearful intravitreal injection amenable treatment . This study also evaluate effect needle size post injection intraocular pressure , see small needle may reduce wound leak increase intraocular pressure follow injection . The investigator hypothesize subject eye inject small size needle result great patient comfort injection compare eye inject large needle . The investigator objective reduce discomfort felt patient receive intravitreal injection . The investigator also hypothesize small needle result high post injection pressure , another objective determine affect patient comfort increase risk glaucomatous optic nerve damage .</brief_summary>
	<brief_title>Assessment Comfort Level Following Intravitreal Injection 30 32 Gauge Needles</brief_title>
	<detailed_description />
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>Ability provide write informed consent comply study assessment full duration study Age &gt; 18 year Subject 's normal therapeutic regimen call receive two session bilateral injection volume ranibizumab within next year . Disease related consideration : None . Other consideration : Subjects must able report pain score 48 hour follow intravitreal injection . Also , subject must consent least 5 intraocular pressure check per eye injection procedure . Pregnancy ( positive pregnancy test ) lactation Premenopausal woman use adequate contraception . The following consider effective mean contraception : surgical sterilization use oral contraceptive , barrier contraception either condom diaphragm conjunction spermicidal gel , intrauterine device , contraceptive hormone implant patch . Any condition investigator believe would pose significant hazard subject investigational therapy initiate special class subject ( vulnerable subject ) , fetuses , pregnant woman , child , institutionalize mentally disabled , others , especially whose ability give voluntary inform consent may question .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Intravitreal injection</keyword>
	<keyword>Needle size</keyword>
	<keyword>Pain</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Pain follow Intravitreal injection</keyword>
</DOC>